Newsfeeds - Spark Newswire

2 minute read

News

BD Receives Emergency Use Authorization for First At-Home COVID-19 Test to Use Smartphone to Interpret, Deliver Results

Today, 6:55 PM

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BD

BDX

1 minute read

BD’s Automated Molecular Diagnostics Platform Wins FDA Approval, Initial Test For HPV

By Vandana Singh

Today, 6:55 PM

Becton Dickinson and Co (NYSE:BDX) has received FDA approval for its automated, sample-to-answer, high-throughput BD Cor system along with the BD…

BDX

1 minute read

‘Halftime Report’ Traders Share Their Thoughts On Leslie’s, Zynga And More

By Craig Jones

Today, 6:55 PM

On CNBC's "Fast Money Halftime Report," Josh Brown said he is still holding Leslie's Inc (NASDAQ: LESL) and he still believes in it.

BDX

1 minute read

JPMorgan Downgrades Becton Dickinson On Muffled FY22 Outlook

By Vandana Singh

Today, 6:55 PM

JPMorgan downgraded Becton Dickinson and Co (NYSE:BDX) to Neutral from Overweight with a price target of $265, down from $280. While Becton reported…

BDX

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 6, 2021

By Benzinga Insights

Today, 6:55 PM

ADTN

1 minute read

10 Biggest Price Target Changes For Friday

By Lisa Levin

Today, 6:55 PM

Piper Sandler boosted the price target for Moderna, Inc. (NASDAQ: MRNA) from $246 to $445. Moderna shares fell 1.6% to $409.55 in pre-market trading.

BDX

1 minute read

JP Morgan Downgrades Becton, Dickinson to Neutral, Announces $265 Price Target

By Benzinga Newsdesk

Today, 6:55 PM

JP Morgan analyst Robert Marcus downgrades Becton, Dickinson (NYSE:BDX) from Overweight to Neutral and announces $265 price target.

BDX

1 minute read

SVB Leerink Maintains Market Perform on Becton, Dickinson, Lowers Price Target to $250

By Benzinga Newsdesk

Today, 6:55 PM

SVB Leerink analyst Richard Newitter maintains Becton, Dickinson (NYSE:BDX) with a Market Perform and lowers the price target from $260 to $250.

BDX

1 minute read

BDX Stock Plunges Despite Q3 Earnings Topping Estimates On Recovery In Elective Volumes; Raised FY21 Guidance

By Vandana Singh

Today, 6:55 PM

Becton Dickinson and Co (NYSE:BDX) reported Q3 revenues of $4.9 billion, +26.9% Y/Y, better than the consensus of $4.51 billion.…

BDX

1 minute read

Becton, Dickinson: Q3 Earnings Insights

By Benzinga Insights

Today, 6:55 PM

Shares of Becton, Dickinson (NYSE:BDX) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share were up 24.55% year over year to $2.74, which beat the estimate of $2.44.

BDX